Kriya Therapeutics is a clinical-stage biotechnology company developing transformative gene therapies for the treatment of highly prevalent serious diseases. The company's mission is to develop best-in-class gene therapies that restore normal gene function, thereby transforming the lives of patients with serious diseases. Kriya's pipeline includes multiple programs across various therapeutic areas, including ophthalmology, oncology, and rare genetic diseases. The company is headquartered in South San Francisco, California.